Научная электронная библиотека
Монографии, изданные в издательстве Российской Академии Естествознания

ПАРАТГОРМОН-РОДСТВЕННЫЙ ПРОТЕИН

Курзанов А. Н., Ледванов М. Ю., Быков И. М., Медведев В. Л., Стрыгина Е. А., Бизенкова М. Н., Заболотских Н. В., Ковалев Д. В., Стукова Н. Ю.,

Литература к главе 10

1. Бизенкова М.Н., Курзанов А.Н. Остеотропные эффекты паратгормон-родственного белка // Современные проблемы науки и образования. – 2017. – № 2; URL: http://science-education.ru/ru/article/view?id=26328.

2. Курзанов А.Н., Быков И.М., Ледванов М.Ю. Паратиреоидный гормон-родственный белок – современные представления о структуре, биохимических характеристиках и физиологической роли в организме // Современные проблемы науки и образования. – 2016. – № 6; URL: http://science-education.ru/ru/article/view?id=25543.

3. Медведев В.Л., Стрыгина Е.А., Курзанов А.Н. Паратиреоидный гормон-родственный белок и рак предстательной железы. Кубанский научный медицинский вестник. 2017; 1(1): 145-154. https://doi.org/10.25207/1608-6228-2017-1-145-154.

4. Adamson I.Y., Young L., King G.M. Reciprocal epithelial: fibroblast interactions in the control of fetal and adult rat lung cells in culture. Exp Lung Res. 1991; 17: 821–835.

5. Adamson I.Y. Relationship of mesenchymal changes to alveolar epithelial cell differentiation in fetal rat lung. Anat Embryol (Berl). 1992; 185: 275–280.

6. Alcorn D., Adamson T.M., Lambert T.F. et al. Morphological effects of chronic tracheal ligation and drainage in the fetal lamb lung. J Anat. 1997; 123: 649–660.

7. Amabile N., Heiss C., Real W.M., et al. Circulating endothelial microparticles levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med. 1994; 149: 423–9.

8. Barbera L.A., Steinhorn R.H., Roca J., et al. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994; 149: 422–9.

9. Barnes P.J. Nitric oxide and airway disease. Ann Med. 1995; 27: 389–93.

10. Bellusci S., Furuta Y., Rush M.G. et al. Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. Development. 1997; 124: 53–63.

11. Bergwitz C., Klein P., Kohno H. et al. Identification, functional characterization, and developmental expression of two nonallelic parathyroid hormone (PTH)/PTH-related peptide receptor isoforms in Xenopus laevis (Daudin). Endocrinology. 1998; 139: 723–732.

12. Brandt D.W., Burton D.W., Gazdar A.F et al. All major lung cancer cell types produce parathyroid hormone-like protein: heterogeneity assessed by high performance liquid chromatography. Endocrinology. 1991; 129: 2466–2470.

13. Brockhoff B., Schreckenberg R., Forst S. et al. Effect of nitric oxide deficiency on the pulmonary PTHrP system. J Cell Mol Med. 2017; 21 (1): 96-106. doi: 10.1111 / jcmm.12942.

14. Buch S., Han R.N.N., Liu J. et al. Basic fibroblast growth factor and growth factor receptor gene expression in 85 % O2-exposed rat lung. Am J Physiol Lung Cell Mol Physiol. 1995; 268: L455-L464.

15. Buckley S., Bui K.C., Hussain M. Warburton D. Dynamics of TGF-β3 peptide activity during rat alveolar epithelial cell proliferative recovery from acute hyperoxia. Am J Physiol Lung Cell Mol Physiol. 1996; 271: L54-L60.

16. Burtis W.J., Brady T.G., Orloff J.J. et al. Immunochemical characterization ofcirculating parathyroid hormone-related protein in patients with humoralhypercalcemia of cancer. N Engl J Med 1990; 322: 1106–1112.

17. Cai Z., Chen Q., Chen J. et al. Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo. Neoplasia. 2009; 11:228–236. doi: 10.1593/neo.81282.

18. Campos R.V., Asa S.L., Drucker D.J. Immunocytochemical localization of parathyroid hormone-like peptide in the rat fetus. Cancer Res. 1991; 51(23 Pt 1): 6351-7.

19. Cardoso, W.V. Molecular regulation of lung development. Annu. Rev. Physiol. 2001; 63: 471–494.

20. Clements, J.A., J. Nellenbogen, H.J. Trahan. Pulmonary surfactant and evolution of the lungs. Science. 1970; 169: 603–604.

21. Coggins M.P., Bloch K.D. Nitric oxide in the pulmonary vasculature. Arterioscler Thromb Vasc Biol. 2007; 27: 1877–985.

22. Coleman R.E. Skeletal complications of malignancy. Cancer 1997; 80: 1588–1594.

23. Daniels C.B., Orgeig S. Pulmonary surfactant: the key to the evolution of air breathing. News Physiol. Sci. 2003; 18: 151–157.

24. DeMarco V.G., Habibi J., Whaley-Connell A.T. et al. Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rats. Am J Physiol Heart Circ Physiol. 2009; 297: H1128–39.

25. Demayo F., Minoo P., Plopper C.G. et al. Mesenchymal-epithelial interactions in lung development and repair: are modeling and remodeling the same process? Am. J. Physiol. (Lung Cell Mol. Physiol.) 2002; 283: L510–L517.

26. Deng X., Tannehill-Gregg S.H., Nadella M.V. et al. Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases. Clin Exp Metastasis. 2007; 24:107–119. doi: 10.1007/s10585-007-9059-9.

27. Doi T., Sugimoto K., Ruttenstock E. et al Prenatal treatment with retinoic acid activates parathyroid hormone-related protein signaling in the nitrofen-induced hypoplastic lung. Pediatr Surg Int. 2011; 27(1): 47–52. https://doi.org/10.1007/s00383-010-2726-y.

28. Edwards Y.S. Stretch stimulation: its effects on alveolar type II cell function in the lung. Comp Biochem Physiol A Physiol. 2001; 129: 245–260.

29. Farach-Carson M.C., Lin S-H., Nalty T., Satcher R.L. Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow? Front Oncol. 2017; 7: 163. doi: 10.3389/fonc.2017.00163.

30. Faridy E.E., Permutt S., Riley R.L. Effect of ventilation on surface forces in excised dogs′lungs. J Appl Physiol. 1966; 21: 1453–1462.

31. Floegel J., Uhlig S. Kidney calling lung and call back: how organs talk to each other. Nephrol Dial Transplant. 2010; 25: 32–4.

32. Foley J., P. Dann J. Hong J. et al. Parathyroid hormone–related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic breast development. Development. 2001; 128:513–525.

33. Fraser W.D., Robinson J., Lawton R. et al. Clinical and laboratory studies of anew immunoradiometric assay of parathyroid hormone-related protein. Clin Chem. 1993; 39: 414–419.

34. Furugaki K., Moriya Y., Iwai T. et al. Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292. Clin. Exp. Metastasis. 2011; 28(7): 649–659.

35. Gao Y., Raj U.J. Parathyroid Hormone-Related Protein (PTHrP): A New Role as a Pulmonary Vasodilator at Birth. Pediatric Research. 1999; 45: 302A. https://doi.org/10.1203/00006450-199904020-01799.

36. Gaston B., Drazen J.M., Loscalzo J. et al. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med. 1994; 149: 538–51.

37. Grindley J.C., Bellusci S., Perkins D., Hogan B.L.M. Evidence for the involvement of the Gli gene family in embryonic mouse lung development. Dev Biol. 1997;188:337–348. doi: 10.1006/dbio.1997.8644.

38. Hacker A.D. Dietary restriction, polyamines and monocrotaline-induced pulmonary hypertension. Biochem Pharmcol. 1993; 45: 2475–81.

39. Han R.N.N, Han V.K.M., Buch S. et al. Insulin-like growth factor-I and type I insulin-like growth factor receptor in 85 % O2-exposed rat lung. Am J Physiol Lung Cell Mol Physiol. 1996; 271: L139-L149.

40. Hastings R.H., Asirvatham A., Quintana R. et al. Parathyroid hormone-related protein-(38–64) regulates lung cell proliferation after silica injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2002; 283(1): L12-L21. 01 https://doi.org/10.1152/ajplung.00308.2001.

41. Hastings R.H., Berg J.T., Summers-Torres D. et al. Parathyroid hormone-related protein reduces alveolar epithelial cell proliferation during lung injury in rats. Am J Physiol Lung Cell Mol Physiol, 2000; 279: L194-L200.

42. Hastings R.H., Summers-Torres D., Cheung T.C. et al. Parathyroid hormone-related protein, an autocrine regulatory factor for alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol. 1996; 270(3 Pt 1): L353-L361.

43. Hastings R.H., Araiza F., Burton D.W., Deftos L.J. Role of parathyroid hormone-related protein in lung cancer cell survival. Chest. 2004; 125(5 Suppl): 150S.10.1378/chest.125.5_suppl.150S.

44. Hastings R.H., Burton D.W., Quintana R.A. et al. Parathyroid hormone-related protein regulates the growth of orthotopic human lung tumors in athymic mice. Cancer. 2001; 92: 1402–1410.

45. Hastings R.H., Laux A.M., Casillas A. et al. Sex-specific survival advantage with PTHrP in non-small cell lung carcinoma patients. Clin Cancer Res. 2006; 12: 499–506.

46. Hastings R.H., Summers-Torres D., Yaszay B. et al. Parathyroid hormone-related protein, an autocrine growth inhibitor of alveolar type II cells. Am J Physiol Lung Cell Mol Physiol. 1997; 272(3 Pt 1): L394 – L399.

47. Hastings R.H. Parathyroid hormone-related protein and lung biology. Respir Physiol Neurobiol. 2004; 142(2-3):95-113.

48. Hastings R.H., Burton D.W., Nefzi A. et al. Combinatorial library discovery of small molecule inhibitors of lung cancer proliferation and parathyroid hormone-related protein expression. Cancer Biol Ther. 2010; 10(10):1067-75. doi: 10.4161/cbt.10.10.13374.

49. Hastings R.H., Duong H., Burton D.W., Deftos LJ. Alveolar epithelial cells express and secrete parathyroid hormone-related protein. Am J Respir Cell Mol Biol. 1994; 11(6): 701-6.

50. Hastings R.H., Montgrain P.R., Quintana R. et al. Cell cycle actions of parathyroid hormone-related protein in non-small cell lung carcinoma. Am J Physiol Lung Cell Mol Physiol. 2009; 297(4): L578-85. doi: 10.1152/ajplung.90560.2008.

51. Hastings R.H., Montgrain P.R., Quintana R.A. et al. Lung carcinoma progression and survival versus amino- and carboxyl-parathyroid hormone-related protein expression. J Cancer Res Clin Oncol. 2017 Aug; 143(8): 1395-1407. doi: 10.1007/s00432-017-2396-4.

52. Hu E., Tontonoz P., Spiegelman B.M. Transdifferentiation of myoblasts by the adipogenic transcription factors PPARgamma and C/EBP alpha. Proc. Natl. Acad. Sci. USA. 1995; 92: 9856–9860.

53. Hume R., Kelly R., Cossar D. et al. Self-differentiation of human fetal lung organ culture: the role of prostaglandins PGE2 and PGF2 alpha. Exp Cell Res. 1991; 194: 111–117.

54. Iguchi H., Tanaka S., Ozawa Y. et al. An experimental model of bone metastasis by human lung cancer cells: The role of parathyroid hormone-related protein in bone metastasis. Cancer Res. 1996; 56: 4040–4043.

55. Jiang B., Morimoto S., Yang J. et al. Expression of parathyroid hormone/parathyroid hormone-related protein receptor in vascular endothelial cells. J. Cardiovasc. Pharmacol. 1998; 31: S142–S144.

56. Kaesler S., Luscher B., Ruther U. Transcriptional activity of GLI1 is negatively regulated by protein kinase A. Biol. Chem. 2000; 381: 545–551.

57. Kalk P., Mach A., Thone-Reineke C., et al. Pulmonary fibrosis in L-NAME-treated mice is dependent on an activated endothelin system. Can J Physiol Pharmacol. 2008; 86: 541–5.

58. Karaplis A.C. PTHrP: novel roles in skeletal biology. Curr Pharm Des. 2001; 7: 655–670.

59. Karperien M., van Dijk T.B., Hoeijmakers T., et al. Expression pattern of parathyroid hormone/parathyroid hormone-related peptide receptor mRNA in mouse postimplantation embryos indicates involvement in multiple developmental processes. Mech Dev.1994; 47: 29–42

60. Kerem A., Yin J., Kaestle S.M., et al. Lung endothelial dysfunction in congestive heart failure: role of impaired Ca 2+signaling and cytoskeletal reorganization. Circ Res. 2010; 106: 1103–16.

61. Kobs R.W., Chesler N.C. The mechanobiology of pulmonary vascular remodelling in the congential absence of eNOS. Biomechn Model Mechanobiol. 2006; 5: 217–25.

62. Krebs M., Sakurai R., Torday J.S., Rehan V.K. Evidence for in Vivo Nicotine-Induced Alveolar Interstitial Fibroblast-to-Myofibroblast Transdifferentiation. Exp Lung Res. 2010; 36(7): 390–398. doi: 10.3109 / 01902141003714023

63. Lebeche D., Malpel S., Cardoso W.V. Fibroblast growth factor interactions in the developing lung. Mech Dev. 1999; 86: 125–136.

64. Lechner A.J., Winston D.C., Bauman J.E. Lung mechanics, cellularity, and surfactant after prenatal starvation in guinea pigs. J Appl Physiol. 1986; 60: 1610–1614.

65. Lee J.W., Gonzalez R.F., Chapin C.J., et al. Nitric oxide decreases surfactant protein gene expression in primary cultures of type II pneumocytes. Am J Physiol Lung Cell Mol Physiol. 2005; 288: L950–7.

66. Lee K., Deeds J.D., Segre G.V. Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats. Endocrinology. 1995; 136(2): 453-63.

67. Li X., Drucker D.J. Growth factor-like properties of parathyroid hormone-related peptide in transfected rodent cell line. Cancer Res. 1993; 53: 2980–2986.

68. Litingtung Y., Lei L., Westphal H., Chiang C. Sonic hedgehog is essential to foregut development. Nat Genet. 1998; 20: 58–61. doi: 10.1038/1717.

69. Liu M., Tanswell A.K., Post M. Mechanical force-inducedsignal transduction in lung cells. Am J Physiol Lung Cell Mol Physiol. 1999; 277: L667–683.

70. Lopez-Lopez J.G., Moral-Sanz J., Frazziano G., et al. Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction. Am J Physiol Lung Cell Mol Physiol. 2008; 295: L727–32.

71. Lorch G., Gilmore J.L., Koltz P.F., et al. Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice. Br. J. Cancer. 2007; 97(2): 183–193.

72. Maina J.N. Structure, function and evolution of the gas exchangers: comparative perspectives. J. Anat. 2002; 201: 281–304.

73. Maina J.N. Fundamental structural aspects and features in the bioengineering of the gas exchangers: comparative perspectives. Adv. Anat. Embryol. Cell Biol. 2002; 163: 1–112.

74. Maina J.N. Some recent advances on the study and understanding of the functional design of the avian lung: morphological and morphometric perspectives. Biol. Rev. Camb. Philos. Soc. 2002; 77: 97–152.

75. Maksvytis H.J., Vaccaro C., Brody J.S. Isolation and characterization of the lipid-containing interstitial cell from the developing rat lung. Lab Invest. 1981; 45: 248–259.

76. Mariani T.J., Roby J.D., Mecham R.P. et al., Localization of type I procollagen gene expression in silica-induced granulomatous lung disease and implication of transforming growth factor-beta as a mediator of fibrosis. Am J Pathol. 1996; 148: 151-164.

77. McCray P.B. Jr, Bettencourt J.D., Bastacky J. Secretion of lung fluid by the developing fetal rat alveolar epithelium in organ culture. Am J Respir Cell Mol Biol. 1992; 6: 609–616.

78. McDowell S.A., Gammon K., Zingarelli B., et al. Inhibition of nitric oxide restores surfactant gene expression following nickel-induced acute lung injury. Am J Respir Cell Mol Biol. 2003; 28: 188–98.

79. McGowan S., Torday J.S. Pulmonary Lipid Laden Fibroblasts. Annu Rev Physiol. 1999; 59: 45–64.

80. McGowan S.E., Torday J.S. The pulmonary lipofibroblast (lipid interstitial cell) and its contributions to alveolar development. Annu Rev Physiol. 1997; 59: 43–62.

81. Meban C. Thickness of the air-blood barriers in vertebrate lungs. J. Anat. 1980; 131: 299–307.

82. Michaeloudes C., Sukkar M.B., Khorasani N.M., et al. TGF-bregulates Nox4, MnSOD and catalase expression, and IL-6 release in airway smooth muscle cells. Am J Physiol Cell Mol Physiol. 2011; 300: L295–304.

83. Miki T., Yano S., Hanibuchi M., et al. Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice. Int J Cancer. 2004; 108(4): 511–5.10.1002/ijc.11586.

84. Miller B.E., Dethloff L.A., Gladen B.C., Hook G.E. Progression of type II cell hypertrophy and hyperplasia during silica-induced pulmonary inflammation. Lab Invest. 1987; 57: 546-54.

85. Minke van Tuyl, Martin Post. From fruitflies to mammals: mechanisms of signalling via the Sonic hedgehog pathway in lung development. Respir Res. 2000; 1(1): 30–35.

86. Moessinger A.C., Harding R., Adamson T.M., et al. Role of lung fluid volume in growth and maturation of the fetal sheep lung. J Clin Invest. 1990; 86: 1270–1277.

87. Montgrain P.R., Deftos L.J., Arenberg D., et al. Prognostic implications of parathyroid hormone-related protein in males and females with non-small-cell lung cancer. Clin Lung Cancer. 2011; 12(3):197-205. doi: 10.1016/j.cllc.2011.03.018.

88. Montgrain P.R., Phun J., Werff R.V., et al. Parathyroid-hormone-related protein signaling mechanisms in lung carcinoma growth inhibition. Springerplus. 2015; 4: 268. doi: 10.1186/s40064-015-1017-4.

89. Montgrain P.R., Quintana R., Rascon Y., et al. Parathyroid hormone-related protein varies with sex and androgen status in nonsmall cell lung cancer. Cancer. 2007; 110(6): 1313-20.

90. Morales E., Sakurai R., Husain S., et. al. Nebulized PPARγ agonists: a novel approach to augment neonatal lung maturation and injury repair in rats. Pediatr Res. 2014; 75(5): 631-40. doi: 10.1038/pr.2014.8.

91. Moseley J.M., Kubota M., Diefenbach-Jagger H., et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A. 1987; 84(14):5048-52.

92. Muguruma H., Yano S., Kakiuchi S., et al. Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity. Clin Cancer Res. 2005; 11:8822–8828. doi: 10.1158/1078-0432.CCR-05-1335.

93. Nelson G.H. McPherson J.C.Jr. Respiratory distress syndrome in various cultures and a possible role of diet. In: Lung Biology in Health and Disease: Pulmonary Development, edited by Nelson G.H. New York: Dekker, 1985; 27: 159–178.

94. Nicholas T.E., Barr H.A. Control of release of surfactant phospholipids in the isolated perfused rat lung. J Appl Physiol. 1981; 51: 90–98.

95. Nicholas T.E., Bar H.A. The release of surfactant in rat lung by brief periods of hyperventilation. Respir Physiol. 1983; 52:69–83.

96. Nici L., Medina M., Frackelton A.R. The epidermal growth factor receptor network in type 2 pneumocytes exposed to hyperoxia in vitro. Am J Physiol Lung Cell Mol Physiol. 1996; 270: L242-L250.

97. Nielsen H.C., Torday J.S. Sex differences in avian embryo pulmonary surfactant production: evidence for sex chromosome involvement. Endocrinology. 1985; 117:31–37.

98. Nishigaki Y., Ohsaki Y., Toyoshima E., Kikuchi K. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients. Clin Cancer Res. 1999; 5(6): 1473-81.

99. Nunez J.S., Torday J.S. Fetal rat lung type II cells and fibroblasts actively recruit surfactant substrate. J Nutr. 1995; 125: 1639S–1644S.

100. Oyarzun M.J., Clements J.A., Baritussio A. Ventilation enhances pulmonary alveolar clearance of radioactive dipalmi-toyl phosphatidylcholine in liposomes. Am Rev Respir Dis. 1980; 121: 709–721.

101. Pecherstorfer M., Schilling T., Blind E., et al. Parathyroid hormone-relatedprotein and life expectancy in hypercalcemic cancer patients. J Clin Endo-crinol Metab. 1994; 78: 1268–1270.

102. Pepicelli C.V., Lewis P.M., McMahon A.P. Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr Biol. 1998; 8: 1083–1086.

103. Piiper J. Alveolar-capillary gas transfer in lungs: development of concepts and current state. Adv. Exp. Med. Biol. 1994; 345: 7–14.

104. Prisk G.K. Microgravity and the lung. J Appl Physiol. 2000; 89(1): 385-96.

105. Prisk G.K. Microgravity and the respiratory system Eur Respir J. 2014; 43(5): 1459-71. doi: 10.1183/09031936.00001414.

106. Rehan V., Torday J. Hyperoxia augments pulmonary lipofibroblast-to-myofibroblast transdifferentiation. Cell Biochem Biophys. 2003; 38: 239–250.

107. Rehan V.K., John S. Torday J.S. PPARγ Signaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung. PPAR Res. 2012; 289867. doi: 10.1155/2012/289867.

108. Rehan V.K., Torday J.S. Exploiting the PTHrP signaling pathway to treat chronic lung disease. Drugs of today 2007; 43(5): 317-31. DOI: 10.1358/dot.2007.43.5.1062665.

109. Rehan V.K., Asotra K., Torday J.S. The effects of smoking on the developing lung: insights from a biologic model for lung development, homeostasis, and repair. Lung. 2009; 187: 281–9.

110. Rehan V.K., Sakurai R., Wang Y., et al. Reversal of nicotine-induced alveolar lipofibroblast-to-myofibroblast transdifferentiation by stimulants of parathyroid hormone-related protein signalling. Lung. 2007; 185: 151–9.

111. Rehan V.K., Torday J.S. The lung alveolar lipofibroblast: an evolutionary strategy against neonatal hyperoxic lung injury. Antioxid Redox Signal. 2014; 21(13): 1893-1904. doi: 10.1089/ars.2013.5793.

112. Rehan V.K., Wang Y., Sugano S., et al. Mechanism of nicotine-induced pulmonary fibroblast transdifferentiation. Am J Physiol Lung Cell Mol Physiol. 2005; 289: L667–L676.

113. Rizzoli R., Thiebaud D., Bundred N., et al. Serum parathyroid hormone-related protein Levels An Dresponse to bisphosphonate Treatment in hypercalcemia of malignancy. J Clin Endocrinol Metab. 1999; 84:3545–3550.

114. Rodriguez A., Viscardi R.M., Torday J.S. Fetal androgen exposure inhibits fetal rat lung fibroblast lipid uptake and release. Exp Lung Res. 2001; 27: 13–24.

115. Romer A.S. Man and the Vertebrates, Vol. 1. Harmonds-worth, GB: Penguin, 1954.

116. Rubin L.P., Torday J.S. Parathyroid hormone-related protein (PTHrP) biology in fetal lung development. In: Endocrinology of the Lung, edited by Mendelson CR. Totowa, NJ: Humana, 2000, p. 269–297.

117. Rubin L.P., Kovacs C.S., De Paepe M.E., et al., Arrested Pulmonary Alveolar Cytodifferentiation and Defective Surfactant Synthesis in Mice Missing the Gene for Parathyroid Hormone-Related Protein Dev Dyn. 2004; 230 (2): 278-89.

118. Rubin L.P., Kifor O., Hua J., et al. Parathyroid hormone (PTH) and PTH-related protein stimulate surfactant phospholipid synthesis in rat fetal lung, apparently by a mesenchymal-epithelial mechanism. Biochim. Biophys. Acta. 1994; 1223: 91–100.

119. Sakaguchi S., Goto H., Hanibuchi M., et al. Gender difference in bone metastasis of human small cell lung cancer, SBC-5 cells in natural killer-cell depleted severe combined immunodeficient mice. Clin Exp Metastasis. 2010; 27(5):351–359. 10.1007/s10585-010-9333-0.

120. Sakai T., Satoh K., Matsushima K., et al. Hepatocyte growth factor in bronchoalveolar lavage fluids and cells in patients with inflammatory chest diseases of the lower respiratory tract: detection by RIA and in situ hybridization. Am J Respir Cell Mol Biol. 1997; 16: 388-397.

121. Sakurai R., Lee C., Shen H., et al. A Combination of the Aerosolized PPAR-γ Agonist Pioglitazone and a Synthetic Surfactant Protein B Peptide Mimic Prevents Hyperoxia-Induced Neonatal Lung Injury in Rats. Neonatology. 2018; 113(4): 296-304. doi: 10.1159/000486188.

122. Sanchez-Esteban J., Cicchiello L.A., Wang Y., et al. Mechanical stretch promotes alveolar epithelial type II cell differentiation. J Appl Physiol. 2001; 91: 589–595.

123. Sasaki Y., Morimoto T., Saito H., et al. The role of parathyroid hormone-related protein in intra-tracheal fluid. Endocr J 2000; 47: 169–175.

124. Schermer D.T., Chan S.D., Bruce R., et al. Chicken parathyroid hormone-related protein and its expression during embryologic development. J. Bone Miner. Res. 1991; 6:149–155.

125. Schultz C.J., Torres E., Londos C., Torday J.S. Role of adipocyte differentiation-related protein in surfactant phospholipids synthesis by type II cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2002; 283: L288–L296.

126. Shannon J.M. Induction of alveolar type II cell differentiation in fetal tracheal epithelium by grafted distal lung mesenchyme. Dev Biol. 1994; 166: 600–614.

127. Sharifi A.M, Akbarloo N., Darabi R. Investigation of local ACE activity and structural alterations during development of L-NAME-induced hypertension. Pharmacol Res. 2005; 52: 438–44.

128. Simon R.H., Paine R. Participation of pulmonary alveolar epithelial cells in lung inflammation. J Lab Clin Med. 1995; 126: 108-118.

129. Smith B., Post M. Fibroblast-pneumonocyte factor. Am J Physiol. 1989;
257: 1, 174–178.

130. Sorokin S. Recent work on the developing lungs. In: deHaan R.L., Ursprung H., editors. Organogenesis. New York: Holt; 1965. pp. 467–491.

131. Speziale M.V., Mannino F.L., Hastings R.H., Deftos L.J. Parathyroid hormone-related protein in tracheal aspirates of newborn infants. Pediatr Res. 1998; 43: 660–665.

132. Stern J-B., Bernard O., Paugam C., et al. Prenatal treatment with retinoic acid activates parathyroid hormone-related protein signaling in the nitrofen-induced hypoplastic lung. Pediatr Surg Int. 2011; 27(1): 47–52. https://doi.org/10.1007/s00383-010-2726-y.

133. Stern J-B., Bernard O., Paugam C., et al. Parathyroid hormone-related protein in epithelial lining fluid in humans negatively correlates with the severity of lung injury. Chest. 2002; 121: 852–7.

134. Stewart A.F. Hypercalcemia associated with cancer. N Engl J Med. 2005; 352:373–379.

135. Sun P., Wang J. Effect of nitric oxide lung surfactant secretion. Exptl Lung Res. 2003; 29: 303–14.

136. Taderera J.V. Control of lung differentiation in vitro. Dev Biol. 1967; 16: 489–512.

137. Te K.G., Reggiani C. Skeletal muscle fibre type specification during embryonic development. J. Muscle Res. Cell Motil. 2002; 23:65–69.

138. Torday J.S., Rehan V.K. Deconvoluting Lung Evolution Using Functional/Comparative Genomics. American Journal of Respiratory Cell and Molecular Biology. 2004; 31(1): 8-12.

139. Torday J.S., Rehan V.K. Lung evolution as a cipher for physiology. Physiol Genomics. 2009; 38(1): 1–6.

140. Torday J.S., Rehan V.K. On the evolution of the pulmonary alveolar lipofibroblast. Exp Cell Res. 2016; 340(2): 215-9. doi: 10.1016/j.yexcr.2015.12.004.

141. Torday J.S., Rehan V.K. The evolutionary continuum from lung development to homeostasis and repair Am. J. Physiol. Lung Cell. Mol. Physiol. 2007; 292: L608-L611.

142. Torday J.S., Hua J., Slavin R. Metabolism and fate of fetal rat lung fibroblast neutral lipids. Biochim Biophys Acta. 1995; 1254: 198–206.

143. Torday J.S., Rehan V.K. Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatr Res., 2007; 62 (1): 2–7.

144. Torday J.S., Rehan V.K. Evolutionary Biology, Cell-Cell Signaling and Complex Disease. Hoboken, NJ: Wiley, 2012.

145. Torday J.S., Rehan V.K. Mechanotransduction determines the structure and function of lung and bone: a theoretical model for the pathophysiology of chronic disease. Cell Biochem Biophys. 2003; 37: 235–246.

146. Torday J.S., Sanchez-Esteban J., Rubin L.P. Paracrine mediators of mechanotransduction in lung development. Am J Med Sci. 1998; 316: 205–208.

147. Torday J.S., Sun H., Qin J. Prostaglandin E2 integrates the effects of fluid distension and glucocorticoid on lung maturation. Am J Physiol Lung Cell Mol Physiol. 1998; 274: L106–L111.

148. Torday J.S., Sun H., Wang L., et al. Leptin mediates the parathyroid hormone-related protein paracrine stimulation of fetal lung maturation. Am J Physiol Lung Cell Mol Physiol. 2002; 282: L405–L410.

149. Torday J.S., Torday D.P., Gutnick J., Rehan V. Biologic role of fetal lung fibroblast triglycerides as antioxidants. Pediatr Res 49: 843–849, 2001.

150. Torday J.S., Tsai S.-W., Sun H., Rubin L.P. The physiologic role of fluid deformation in fetal lung development. Cellular deformation: Mechanics and Mechanisms of Physiologic Response. Am J Med Sci. 1998; 316: 208–218.

151. Torday J.S. Parathyroid hormone-related protein is a gravisensor in lung and bone cell biology. Adv Space Res. 2003; 32:1569–76. doi:10.1016/S0273-1177(03)90397-8

152. Torday J.S. Cellular timing of fetal lung development. Semin. Perinatol. 1992; 16:130–139.

153. Torday J.S., Torres E., Rehan V.K. The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro. Pediatr. Pathol. Mol. Med. 2003; 22: 189–207.

154. Torday J.S., Rehan V.K. Stretch-stimulated surfactant synthesis is coordinated by the paracrine actions of PTHrP and leptin. Am J Physiol Lung Cell Mol Physiol. 2002; 283: L130–L135.

155. Uhal B.D. Cell cycle kinetics in the alveolar epithelium. Am J Physiol Lung Cell Mol Physiol. 1997; 272: L1031-L1045.

156. Uy H.L., Mundy G.R., Boyce B.F., et al. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo. Cancer Res. 1997; 57: 3194–3199.

157. Valino F., Casals C., Guerrero R., et al. Inhaled nitric oxide affects endogenous surfactant in experimental lung transplantation. Transplantation. 2004; 77: 812–8.

158. Vyas-Read S., Shaul P.W., Yuhanna I.S., et al. Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2007; 293: L212–21.

159. Wang Y., Santos J., Sakurai R., et al. Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model. Pediatr Res. 2009; 65(2):150-5. doi: 10.1203/PDR.0b013e3181938c40.

160. Weibel E.R., Taylor C.R., Bolis L. 1998. Principles of Animal Design. Cambridge University Press. 1998; pp. 178–185.

161. Wirtz H.R., Dobbs LG. Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells. Science 1990; 250:1266–1269.

162. Wu C.E., Wang C.W., Huang W.K., et al. Cytoplasmic and nuclear parathyroid hormone-related proteins are opposing prognostic factors in patients with non-small-cell lung cancer who have undergone curative resection. Jpn J Clin Oncol. 2015; 45(3):267-73. doi: 10.1093/jjco/hyu202.

163. Wyszogrodski I., Kyei-Aboagye K., Taeusch H.W.Jr, Avery E. Surfactant inactivation by hyperventilation: conservation by end-expiratory pressure. J Appl Physiol. 1975; 38: 461–466.

164. Yildrim A.O., Bulau P., Zakrzewicz D., et al. Increased protein argininemethylation in chronic hypoxia. Am J Respir Cell Mol Biol. 2006; 35: 436–43.

165. Zhao J., Chen H., Wang Y.L., Warburton D. Abrogation of tumor necrosis factor-alpha converting enzyme inhibits embryonic lung morphogenesis in culture. Int J Dev Biol. 2001; 45: 623–631.

166. Zhao Y-Y., Zhao Y.D., Mirza M.K., et al. Persistent eNOS activation secondary to caveolin1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest. 2009; 119: 2009–18.


Предлагаем вашему вниманию журналы, издающиеся в издательстве «Академия Естествознания»
(Высокий импакт-фактор РИНЦ, тематика журналов охватывает все научные направления)

«Фундаментальные исследования» список ВАК ИФ РИНЦ = 1.252